{"_id":"YGYrZvv4ky48Jf8K8","bibbaseid":"xia-wang-dong-wang-lu-p7206nlrp4mediatedtypeiinterferonresponsebenefitsimmunecheckpointtherapythroughredirectingcd8tcelldistributionintme-2021","author_short":["Xia, L.","Wang, H.","Dong, H.","Wang, Y.","Lu, S."],"bibdata":{"bibtype":"article","type":"article","author":[{"firstnames":["Leiming"],"propositions":[],"lastnames":["Xia"],"suffixes":[]},{"firstnames":["H."],"propositions":[],"lastnames":["Wang"],"suffixes":[]},{"firstnames":["Haibo"],"propositions":[],"lastnames":["Dong"],"suffixes":[]},{"firstnames":["Y."],"propositions":[],"lastnames":["Wang"],"suffixes":[]},{"firstnames":["Sumin"],"propositions":[],"lastnames":["Lu"],"suffixes":[]}],"title":"P72.06 NLRP4-Mediated Type I Interferon Response Benefits Immune Checkpoint Therapy Through Redirecting CD8+ T Cell Distribution in TME","year":"2021","journal":"Journal of Thoracic Oncology","url":"https://doi.org/10.1016/j.jtho.2021.01.1024","bibtex":"@article{1030,\n author = {Leiming Xia and H. Wang and Haibo Dong and Y. Wang and Sumin Lu},\n title = {P72.06 NLRP4-Mediated Type I Interferon Response Benefits Immune Checkpoint Therapy Through Redirecting CD8+ T Cell Distribution in TME},\n year = {2021},\n journal = {Journal of Thoracic Oncology},\n url = {https://doi.org/10.1016/j.jtho.2021.01.1024}\n}\n\n","author_short":["Xia, L.","Wang, H.","Dong, H.","Wang, Y.","Lu, S."],"key":"1030","id":"1030","bibbaseid":"xia-wang-dong-wang-lu-p7206nlrp4mediatedtypeiinterferonresponsebenefitsimmunecheckpointtherapythroughredirectingcd8tcelldistributionintme-2021","role":"author","urls":{"Paper":"https://doi.org/10.1016/j.jtho.2021.01.1024"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/fFERMKNwKyHLsDPJ3/Link_Lab_Publications.bib","dataSources":["mwAui9iKniQyhTc49","RbCkvcfqfbgtxTyNT"],"keywords":[],"search_terms":["p72","nlrp4","mediated","type","interferon","response","benefits","immune","checkpoint","therapy","through","redirecting","cd8","cell","distribution","tme","xia","wang","dong","wang","lu"],"title":"P72.06 NLRP4-Mediated Type I Interferon Response Benefits Immune Checkpoint Therapy Through Redirecting CD8+ T Cell Distribution in TME","year":2021}